Qube Research & Technologies LTD 2seventy Bio, Inc. Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$3.14 - $11.2 $104,502 - $372,747
33,281 New
33,281 $130,000
Q4 2022

Feb 14, 2023
BUY
$8.57 - $17.0 $436,024 - $864,926
50,878 New
50,878 $476,000
Q2 2022

Aug 15, 2022
BUY
$10.55 - $18.81 $820,357 - $1.46 Million
77,759 New
77,759 $1.03 Million

Others Institutions Holding TSVT

# of Institutions
126
Shares Held
45.6M
Call Options Held
122K
Put Options Held
19.8K
View Full List

About 2seventy bio, Inc.

TSVT Quotes by TradingView
  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $140M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email